We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 26.46%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+26.46%
3 Year Est. Return
+80.44%
5 Year Est. Return
+106.59%
10 Year Est. Return
+436.91%
AUM
$452M
AUM Growth
-$4.06M
Cap. Flow
-$1.04M
Cap. Flow %
-0.23%
Top 10 Hldgs %
21.76%
Holding
443
New
25
Increased
18
Reduced
19
Closed
20

Top Buys

Rank Stock Value
1
FLS icon
Flowserve
FLS
+$1.05M
2
AAL icon
American Airlines Group
AAL
+$943K
3
APTV icon
Aptiv
APTV
+$438K
4
BKR icon
Baker Hughes
BKR
+$433K
5
KHC icon
Kraft Heinz
KHC
+$425K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$701K
2
SPG icon
Simon Property Group
SPG
+$668K
3
CMCSA icon
Comcast
CMCSA
+$643K
4
NKTR icon
Nektar Therapeutics
NKTR
+$606K
5
PEP icon
PepsiCo
PEP
+$507K

Sector Composition

Rank Sector Weight
1 Technology 19.36%
2 Financials 17.3%
3 Healthcare 15.08%
4 Communication Services 10.39%
5 Consumer Discretionary 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
26
NVIDIA
NVDA
$4.72T
$3.22M 0.71%
555,440
– –
MRK icon
27
Merck
MRK
$321B
$3.2M 0.71%
61,524
-6,571
-10% -$355K
ORCL icon
28
Oracle
ORCL
$367B
$3.06M 0.68%
66,828
– –
WMT icon
29
Walmart Inc
WMT
$884B
$3.03M 0.67%
102,318
– –
AMGN icon
30
Amgen
AMGN
$209B
$2.96M 0.66%
17,379
– –
ABT icon
31
Abbott
ABT
$183B
$2.92M 0.65%
48,721
– –
NFLX icon
32
Netflix
NFLX
$305B
$2.89M 0.64%
97,920
– –
TXN icon
33
Texas Instruments
TXN
$255B
$2.88M 0.64%
27,773
– –
CMCSA icon
34
Comcast
CMCSA
$84B
$2.69M 0.59%
78,601
-16,580
-17% -$643K
OXY icon
35
Occidental Petroleum
OXY
$55.6B
$2.69M 0.59%
41,350
+2,480
+6% +$173K
ACN icon
36
Accenture
ACN
$99.9B
$2.67M 0.59%
17,359
– –
CB icon
37
Chubb
CB
$135B
$2.58M 0.57%
18,877
– –
MDT icon
38
Medtronic
MDT
$110B
$2.56M 0.57%
31,911
– –
USB icon
39
US Bancorp
USB
$98B
$2.54M 0.56%
50,402
– –
DHR icon
40
Danaher
DHR
$138B
$2.51M 0.56%
28,968
– –
SLB icon
41
SLB Ltd
SLB
$72.6B
$2.5M 0.55%
38,646
– –
IBM icon
42
IBM
IBM
$209B
$2.49M 0.55%
17,000
– –
ITW icon
43
Illinois Tool Works
ITW
$81.6B
$2.42M 0.54%
15,449
– –
TMO icon
44
Thermo Fisher Scientific
TMO
$214B
$2.4M 0.53%
11,629
– –
BMY icon
45
Bristol-Myers Squibb
BMY
$132B
$2.34M 0.52%
36,928
– –
ADBE icon
46
Adobe
ADBE
$98.5B
$2.33M 0.52%
10,776
– –
PNC icon
47
PNC Financial Services
PNC
$99.2B
$2.31M 0.51%
15,294
– –
PX
48
DELISTED
Praxair Inc
PX
$2.31M 0.51%
15,975
– –
GILD icon
49
Gilead Sciences
GILD
$163B
$2.3M 0.51%
30,521
– –
UNP icon
50
Union Pacific
UNP
$172B
$2.25M 0.5%
16,708
– –
1
2
3 4 5

Similar funds

LIA
LBMC Investment Advisors Brentwood, Tennessee $1.64B AUM 15.26% 1-Year Est. Return
GA
Greenspring Advisors Towson, Maryland $1.64B AUM
AHC
Adell Harriman & Carpenter Houston, Texas $1.64B AUM 36.77% 1-Year Est. Return
UMC
UNC Management Company Chapel Hill, North Carolina $1.64B AUM 17.65% 1-Year Est. Return
1SP
140 Summer Partners New York $1.64B AUM 47.44% 1-Year Est. Return
MRG
Milestone Resources Group Road Town Tortola, British Virgin Islands $1.64B AUM 7.52% 1-Year Est. Return
TIAA Trust, National Association
TIAA Trust, National Association Charlotte, North Carolina $1.65B AUM 16.63% 1-Year Est. Return
TCA
Troluce Capital Advisors Dorado, Puerto Rico $1.63B AUM 37.23% 1-Year Est. Return

Everence Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Everence Capital Management held 443 positions worth $452M, down 0.89% from $456M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Everence Capital Management's Q1 2018 filing shows 25 new, 18 increased, 19 reduced and 20 closed positions. Its largest new stake was Flowserve: 24,000 shares worth $1.04M. The largest sale was Apple, an estimated $701K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Everence Capital Management's largest Q1 2018 buy was Flowserve: 24,000 shares worth $1.04M.
  • Everence Capital Management added most to Baker Hughes in Q1 2018, an estimated $433K increase.
  • Everence Capital Management's biggest Q1 2018 reduction was Apple, cutting an estimated $701K.
  • Everence Capital Management fully exited Nektar Therapeutics in Q1 2018, selling an estimated $606K.
  • Everence Capital Management's ten largest holdings make up 22% of its $452M portfolio in Q1 2018.
  • Everence Capital Management opened 25 new positions and closed 20 in Q1 2018.
  • Everence Capital Management's portfolio value fell 0.89% quarter-over-quarter to $452M.

Based on Everence Capital Management's 13F filing for Q1 2018, filed 30 Apr 2018.